Published in Rheumatology (Oxford) on February 24, 2004
Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial. Rheumatology (Oxford) (2011) 1.03
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs? BMC Med (2013) 0.82
Clinical approaches to early inflammatory arthritis. Nat Rev Rheumatol (2009) 0.80
Rheumatoid factor positivity is associated with increased joint destruction and upregulation of matrix metalloproteinase 9 and cathepsin k gene expression in the peripheral blood in rheumatoid arthritic patients treated with methotrexate. Int J Rheumatol (2013) 0.79
How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience. Rheumatology (Oxford) (2005) 0.75
How aggressive should initial therapy for rheumatoid arthritis be? Rheumatology (Oxford) (2005) 0.75
Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63
The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med (1992) 3.36
Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20
T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06
Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med (1994) 2.98
CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest (1996) 2.95
Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum (1999) 2.90
Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78
The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum (1998) 2.74
T cell activation in rheumatoid synovium is B cell dependent. J Immunol (2001) 2.73
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation (2000) 2.56
Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest (1999) 2.51
Prospective hemorrhage risk of intracerebral cavernous malformations. Neurology (2012) 2.43
Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology (2002) 2.41
Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med (2001) 2.41
Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A (1998) 2.33
Remote cerebellar hemorrhage after supratentorial surgery. Neurosurgery (2001) 2.30
Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum (1993) 2.11
Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum (1997) 2.11
Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest (1992) 2.09
Single-channel and whole-cell recordings of mitogen-regulated inward currents in human cloned helper T lymphocytes. Nature (1986) 1.78
Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol (2000) 1.73
Down-regulation of CD28 expression by TNF-alpha. J Immunol (2001) 1.65
Modulation of CD4 by antigenic activation. J Immunol (1987) 1.63
Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum (1998) 1.56
Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology (2003) 1.56
CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum (2001) 1.55
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides. Arthritis Rheum (1998) 1.55
The efficacy of epidural blood patch in spontaneous CSF leaks. Neurology (2001) 1.54
Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest (1996) 1.54
Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity. J Biol Chem (1998) 1.52
Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med (1994) 1.52
The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. J Immunol (1998) 1.50
Persistent suppression of virus-specific cytotoxic T cell responses after transient depletion of CD4+ T cells in vivo. J Immunol (1989) 1.47
Ectopic lymphoid organogenesis: a fast track for autoimmunity. Am J Pathol (2001) 1.46
The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. J Rheumatol (1996) 1.45
Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum (1997) 1.44
Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4. J Exp Med (1986) 1.43
Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol (1996) 1.43
Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. Arthritis Rheum (2000) 1.42
Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.42
Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol (1999) 1.41
Functional properties of CD4+ CD28- T cells in the aging immune system. Mech Ageing Dev (1998) 1.41
Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients. J Immunol (1998) 1.40
Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol (2001) 1.39
Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells. J Immunol (2000) 1.38
Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Pathol (1997) 1.38
Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. J Clin Invest (1994) 1.37
Pathogenesis of rheumatoid arthritis. Med Clin North Am (1997) 1.35
Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med (1999) 1.34
Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol (1999) 1.32
Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology (2004) 1.30
Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest (1999) 1.30
Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin Immunopathol (1998) 1.30
Resective reoperation for failed epilepsy surgery: seizure outcome in 64 patients. Neurology (2004) 1.29
Triggering of T-lymphocytes via either T3-Ti or T11 surface structures opens a voltage-insensitive plasma membrane calcium-permeable channel: requirement for interleukin-2 gene function. J Biol Chem (1989) 1.28
Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. J Clin Invest (1994) 1.26
Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways. J Immunol (2000) 1.25
Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest (1997) 1.24
Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest (1995) 1.24
HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum (1994) 1.23
Tissue-destructive macrophages in giant cell arteritis. Circ Res (1999) 1.23
Giant cell vasculitis is a T cell-dependent disease. Mol Med (1997) 1.23
The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest (1992) 1.23